| Name | Title | Contact Details |
|---|
Harlan County Health System is a Alma, NE-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Bioptigen is a Durham, NC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Hearthstone Alzheimer Care provides full service management, consulting and training services to providers of Assisted Living, Nursing Home, Day Care and related healthcare services. Our core group of consultants represent decades of expertise in diverse
The Home Instead Senior Care® network is the world`s leading provider of personalized in-home care services. We have over 1,100 independently owned and operated franchise offices worldwide that employ compassionate CAREGivers who share our dedication to enhancing the lives of aging adults and their families. Services span the care continuum, from companionship and personal care to specialized Alzheimer`s care and hospice support. Caring for others is part of our DNA, and that includes caring for your career. The Home Instead Senior Care network provides best-in-class training, education, and opportunities for career advancement. It also offers you the opportunity to be part of a supportive family-like culture where you`re encouraged to talk with your local office for support, share stories, and seek guidance.
Aimmune is a clinical-stage biopharmaceutical company advancing a new therapeutic approach, including the development of proprietary product candidates, for the treatment of peanut and other food allergies. Our mission is to improve the lives of people with food allergies by developing and commercializing proprietary desensitization therapies that safely and reliably protect them from accidental exposure to food allergens. We aim to address food allergies by providing a treatment option that goes beyond the current protocols of avoiding exposure to food allergens and carrying epinephrine for administration in case of accidental exposure. Our CODIT™ system is based on extensive independent scientific research demonstrating that most patients with food allergies can become desensitized to the allergens, or proteins, in a particular food through the oral administration of gradually increasing amounts of the allergens. In oral immunotherapy (OIT), a very small amount of an allergen is administered on a daily basis and then regularly increased until desensitization to a certain amount of the allergen has been achieved. We plan to develop and commercialize standardized, pharmaceutical-grade food allergens for our CODIT™ (characterized oral desensitization immunotherapy) system, our system for OIT. Our lead product candidate, AR101, is a standardized, complex mixture of 13 naturally occurring proteins and pharmaceutical-grade ingredients that, with the CODIT system of gradual, controlled updosing and ongoing maintenance dosing, has obtained meaningful desensitization to peanut allergens in our initial clinical studies.